Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Emmaus Life Sciences, Inc., its revenue in fiscal 2025 came from these product and service lines: Endari - US $9.05 million (73%), Endari - International $3.18 million (26%), Other $220,000 (2%).
No investor of CNS Response, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 12 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by CNS Response, Inc.
Name
Role
Named in
Joseph Sherwood
Executive officer
Oct 2020
Willis Lee
Executive officer
Oct 2020
Yutaka Niihara
Executive officer
Oct 2020
Daniel T. Hoffman
Executive officer
May 2011
George Carpenter
Executive officer
May 2011
Michael T. Darkoch
Executive officer
May 2011
Paul T. Buck
Executive officer
May 2011
Daniel Hoffman
Executive officer
Oct 2010
Michael Darkoch
Executive officer
Oct 2010
Paul Buck
Executive officer
Oct 2010
Daniel A. Hoffman
Executive officer
Mar 2010
George B. Carpenter
Executive officer
Mar 2010
Paul A. Buck
Executive officer
Mar 2010
Daniel A Hoffman
Executive officer
Sep 2009
Mark Desrosiers
Executive officer
Sep 2009
Ian Pine Zwicker
Director
Oct 2020
Jane Pine Wood
Director
Oct 2020
Masaharu Osato
Director
Oct 2020
Robert Dickey
Director
Oct 2020
Wei Peu Zen
Director
Oct 2020
Willis Lee
Director
Oct 2020
Yutaka Niihara
Director
Oct 2020
David B. Jones
Director
May 2011
George Carpenter
Director
May 2011
George T. Kallins
Director
May 2011
Henry T. Harbin
Director
May 2011
Jerome B. Vaccaro
Director
May 2011
John Pappajohn
Director
May 2011
David Jones
Director
Oct 2010
George Kallins
Director
Oct 2010
Henry Harbin
Director
Oct 2010
Jerome Vaccaro
Director
Oct 2010
George B. Carpenter
Director
Mar 2010
John B. Pappajohn
Director
Mar 2010
Tommy B. Thompson
Director
Mar 2010
Len Brandt
Director
Sep 2009
Went public since 2012. Its SEC number is that of a company listed on a stock exchange.